The isolation of adeno-associated virus (AAV) genomes from biomaterials at the molecular level has traditionally relied on polymerase chain reaction-based and cloning-based techniques. However, when applied to samples containing multiple species, traditional techniques for isolating viral genomes can amplify artificial recombinants and introduce polymerase misincorporation errors. In this study, we describe AAV single-genome amplification (AAV-SGA): a powerful technique to isolate, amplify, and sequence single AAV genomes from mammalian genomic DNA, which can then be used to construct vectors for gene therapy. We used AAV-SGA to precisely isolate 15 novel AAV genomes belonging to AAV clades A, D, and E and the Fringe outgroup. This technique also enables investigations of AAV population dynamics and recombination events to provide insights into virus–host interactions and virus biology. Using AAV-SGA, we identified regional heterogeneity within AAV populations from different lobes of the liver of a rhesus macaque and found evidence of frequent genomic recombination between AAV populations. This study highlights the strengths of AAV-SGA and demonstrates its capability to provide valuable insights into the biology and diversity of AAVs.
Get full access to this article
View all access options for this article.
References
1.
GaoG, VandenbergheLH, AlviraMR, et al.Clades of adeno-associated viruses are widely disseminated in human tissues. J Virol, 2004; 78(12):6381–6388; doi: 10.1128/JVI.78.12.6381-6388.2004.
2.
BelloA, TranK, ChandA, et al.Isolation and evaluation of novel adeno-associated virus sequences from porcine tissues. Gene ther, 2009; 16(11):1320–1328; https://doi.org/10.1038/gt.2009.82.
3.
ChenC-L, JensenRL, SchneppBC, et al.Molecular characterization of adeno-associated viruses infecting children. J Virol, 2005; 79(23):14781–14792; doi: 10.1128/JVI.79.23.14781-14792.2005.
4.
GaoG-P, AlviraMR, WangL, et al.Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci U S A, 2002; 99(18):11854–11859; doi: 10.1073/pnas.182412299.
5.
MoriS, WangL, TakeuchiT, et al.Two novel adeno-associated viruses from cynomolgus monkey: Pseudotyping characterization of capsid protein. Virology, 2004; 330(2):375–383; doi: 10.1016/j.virol.2004.10.012.
6.
WangQ, NambiarK, WilsonJM. Isolating natural adeno-associated viruses from primate tissues with a high-fidelity polymerase. Hum Gene Ther, 2021; 32(23–24):1439–1449; doi: 10.1089/hum.2021.055.
SonntagF, SchmidtK, KleinschmidtJA. A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc Natl Acad Sci U S A, 2010; 107(22):10220–10225; doi: 10.1073/pnas.1001673107.
9.
ElmoreZC, Patrick HavlikL, OhDK, et al. The membrane associated accessory protein is an adeno-associated viral egress factor. Nat Commun, 2021; 12(1):6239; https://doi.org/10.1038/s41467-021-26485-4.
10.
OgdenPJ, KelsicED, SinaiS, et al.Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design. Science, 2019; 366(6469):1139–1143; doi: 10.1126/science.aaw2900.
11.
AsokanA, SchafferDV, SamulskiRJ. The AAV vector toolkit: Poised at the clinical crossroads. Mol Ther, 2012; 20(4):699–708; doi: 10.1038/mt.2011.287.
12.
ArmstrongDK, CunninghamS, DaviesJC, et al.Gene therapy in cystic fibrosis. Arch Dis Child, 2014; 99(5):465–468; DOI:10.1136/archdischild-2012-302158.
13.
DingW, ZhangL, YanZ, et al.Intracellular trafficking of adeno-associated viral vectors. Gene therapy, 2005; 12(11):873–880; https://doi.org/10.1038/sj.gt.3302527.11
DudekAM, PillayS, PuschnikAS, et al.An alternate route for adeno-associated virus entry independent of AAVR. J Virology, 2018; 92(7):e02213-02217; doi: 10.1128/JVI.02213-17.
16.
MartinDP, LemeyP, LottM, et al.RDP3: A flexible and fast computer program for analyzing recombination. Bioinformatics, 2010; 26(19):2462–2463; doi: 10.1093/bioinformatics/btq467.
17.
Salazar-GonzalezJF, BailesE, PhamKT, et al.Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol, 2008; 82(8):3952–3970; doi: 10.1128/JVI.02660-07.
18.
GaoG, VandenbergheLH, WilsonJM. New recombinant serotypes of AAV vectors. Curr Gene Ther, 2005; 5(3):285–297; doi: 10.2174/1566523054065057.
19.
GaoG, AlviraMR, SomanathanS, et al.Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc Natl Acad Sci U S A, 2003; 100(10):6081–6086; doi: 10.1073/pnas.0937739100.
20.
TakeuchiY, MyersR, DanosO. Recombination and population mosaic of a multifunctional viral gene, adeno-associated virus cap. PLoS One, 2008; 3(2):e1634; doi: 10.1371/journal.pone.0001634.
21.
LoyDE, PlenderleithLJ, SundararamanSA, et al.Evolutionary history of human Plasmodium vivax revealed by genome-wide analyses of related ape parasites. Proc Natl Acad Sci U S A, 2018; 115(36):E8450-E8459; https://doi.org/10.1073/pnas.1810053115.
22.
HedegaardDL, TullyDC, RoweIA, et al.High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease. J Hepatol, 2017; 66(1):28–38; doi: 10.1016/j.jhep.2016.07.048.
23.
KeeleBF, GiorgiEE, Salazar-GonzalezJF, et al.Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A, 2008; 105(21):7552–7557; doi: 10.1073/pnas.0802203105.
24.
PalmerS, KearneyM, MaldarelliF, et al.Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol, 2005; 43(1):406–413; doi: 10.1128/JCM.43.1.406-413.2005.
25.
OdelbergSJ, WeissRB, HataA, et al.Template-switching during DNA synthesis by Thermus aquaticus DNA polymerase I. Nucleic Acids Res, 1995; 23(11):2049–2057; doi: 10.1093/nar/23.11.2049.
26.
HsuHL, BrownA, LovelandAB, et al. Structural characterization of a novel human adeno-associated virus capsid with neurotropic properties. Nat Commun, 2020; 11(1):3279; https://doi.org/10.1038/s41467-020-17047-1.
27.
BruntEM, GouwAS, HubscherSG, et al.Pathology of the liver sinusoids. Histopathology, 2014; 64(7):907–920; https://doi.org/10.1111/his.12364.
28.
MoriS, TakeuchiT, EnomotoY, et al.Tissue distribution of cynomolgus adeno-associated viruses AAV10, AAV11, and AAVcy.7 in naturally infected monkeys. Arch Virol, 2008; 153(2):375–380; doi: 10.1007/s00705-007-1097-8.
29.
GilesAR, GovindasamyL, SomanathanS, et al.Mapping an adeno-associated virus 9-specific neutralizing epitope to develop next-generation gene delivery vectors. J Virol, 2018; 92(20):e01011-18; doi: 10.1128/JVI.01011-18.
30.
CalcedoR, WilsonJM. Humoral immune response to AAV. Front Immunol, 2013; 4:341; doi: 10.3389/fimmu.2013.00341.
31.
HennMR, BoutwellCL, CharleboisP, et al. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog, 2012; 8(3):e1002529; https://doi.org/10.1371/journal.ppat.1002529.
32.
LeeAJ, DasSR, WangW, et al.Diversifying selection analysis predicts antigenic evolution of 2009 pandemic H1N1 influenza A virus in humans. J Virol, 2015; 89(10):5427–5440; doi: 10.1128/JVI.03636-14.
33.
BellCL, VandenbergheLH, BellP, et al.The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice. J Clin Invest, 2011; 121(6):2427–2435; doi: 10.1172/JCI57367.
34.
AsokanA, HamraJB, GovindasamyL, et al.Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry. J Virol, 2006; 80(18):8961–8969; doi: 10.1128/JVI.00843-06.
35.
BellCL, GurdaBL, Van VlietK, et al.Identification of the galactose binding domain of the adeno-associated virus serotype 9 capsid. J Virol, 2012; 86(13):7326–7333; doi: 10.1128/JVI.00448-12.
36.
BennettAD, WongK, LewisJ, et al.AAV6 K531 serves a dual function in selective receptor and antibody ADK6 recognition. Virology, 2018; 518:369–376; doi: 10.1016/j.virol.2018.03.007.
37.
GurdaBL, RauppC, Popa-WagnerR, et al.Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8. J Virol, 2012; 86(15):7739–7751; doi: 10.1128/JVI.00218-12.
38.
HuangL-Y, PatelA, NgR, et al.Characterization of the adeno-associated virus 1 and 6 sialic acid binding site. J Virol, 2016; 90(11):5219–5230; doi: 10.1128/JVI.00161-16.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
